Compare Stocks: PHLT, CLOV, NEO, and WGS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLOV Clover Health Investments	$4.81 +0.6%	$4.44	$1.58 ▼ $5.59	$2.54B	2.45	4.66 million shs	3.79 million shs
NEO NeoGenomics	$16.66 +2.8%	$17.51	$7.07 ▼ $20.15	$2.08B	1.79	2.57 million shs	2.23 million shs
PHLT Performant Healthcare	$7.75 +0.3%	$7.73	$2.17 ▼ $7.76	$623.41M	0.69	777,549 shs	2.36 million shs
WGS GeneDx	$64.96 +1.8%	$82.23	$32.21 ▼ $170.87	$1.90B	1.95	843,376 shs	526,538 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLOV Clover Health Investments	-0.21%	+2.14%	-0.83%	-0.83%	+86.72%
NEO NeoGenomics	-0.92%	-15.32%	-6.47%	+13.84%	+78.02%
PHLT Performant Healthcare	0.00%	0.00%	0.00%	0.00%	+0.26%
WGS GeneDx	-5.21%	-16.32%	-25.15%	+2.23%	-47.57%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLOV Clover Health Investments	$4.81 +0.6%	$4.44	$1.58 ▼ $5.59	$2.54B	2.45	4.66 million shs	3.79 million shs
NEO NeoGenomics	$16.66 +2.8%	$17.51	$7.07 ▼ $20.15	$2.08B	1.79	2.57 million shs	2.23 million shs
PHLT Performant Healthcare	$7.75 +0.3%	$7.73	$2.17 ▼ $7.76	$623.41M	0.69	777,549 shs	2.36 million shs
WGS GeneDx	$64.96 +1.8%	$82.23	$32.21 ▼ $170.87	$1.90B	1.95	843,376 shs	526,538 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLOV Clover Health Investments	-0.21%	+2.14%	-0.83%	-0.83%	+86.72%
NEO NeoGenomics	-0.92%	-15.32%	-6.47%	+13.84%	+78.02%
PHLT Performant Healthcare	0.00%	0.00%	0.00%	0.00%	+0.26%
WGS GeneDx	-5.21%	-16.32%	-25.15%	+2.23%	-47.57%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLOV Clover Health Investments	2.17	Hold	$4.75	-1.25% Downside
NEO NeoGenomics	2.50	Moderate Buy	$18.17	9.04% Upside
PHLT Performant Healthcare	0.00	N/A	N/A	N/A
WGS GeneDx	2.67	Moderate Buy	$90.86	39.87% Upside

Current Analyst Ratings Breakdown

Latest PHLT, CLOV, NEO, and WGS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/12/2026	NEO NeoGenomics	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/9/2026	WGS GeneDx	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Strong-Buy ➝ Hold
10/7/2026	NEO NeoGenomics	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Overweight
10/6/2026	NEO NeoGenomics	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$19.00 ➝ $22.00
10/1/2026	WGS GeneDx	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$74.00 ➝ $83.00
9/28/2026	NEO NeoGenomics	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Strong-Buy ➝ Hold
9/21/2026	CLOV Clover Health Investments	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
9/14/2026	CLOV Clover Health Investments	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold
9/10/2026	CLOV Clover Health Investments	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$6.00
8/26/2026	WGS GeneDx	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Strong-Buy
8/6/2026	CLOV Clover Health Investments	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Neutral	$4.75 ➝ $5.00

(Data available from 10/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLOV Clover Health Investments	$1.92B	1.33	N/A	N/A	$0.59 per share	8.15
NEO NeoGenomics	$727.33M	2.94	$0.34 per share	48.35	$6.47 per share	2.57
PHLT Performant Healthcare	$137.36M	4.54	N/A	N/A	$0.98 per share	7.91
WGS GeneDx	$427.54M	4.53	$2.33 per share	27.84	$10.54 per share	6.16

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLOV Clover Health Investments	-$85.55M	-$0.05	N/A	28.29	N/A	-0.74%	-4.20%	-2.28%	11/4/2026 (Estimated)
NEO NeoGenomics	-$108.03M	-$0.40	N/A	333.20	N/A	-6.77%	-1.99%	-1.21%	10/27/2026 (Estimated)
PHLT Performant Healthcare	-$9.90M	-$0.01	N/A	N/A	N/A	-0.64%	-0.04%	-0.03%	N/A
WGS GeneDx	-$21.02M	-$3.64	N/A	56.49	N/A	-23.41%	4.12%	2.26%	10/27/2026 (Estimated)

Latest PHLT, CLOV, NEO, and WGS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/4/2026	Q3 2026	CLOV Clover Health Investments	-$0.0038	N/A	N/A	N/A	$740.31 million	N/A
10/27/2026	Q3 2026	NEO NeoGenomics	$0.0546	N/A	N/A	N/A	$206.60 million	N/A
10/27/2026	Q3 2026	WGS GeneDx	$0.0729	N/A	N/A	N/A	$122.93 million	N/A
8/5/2026	Q2 2026	CLOV Clover Health Investments	$0.0386	$0.05	+$0.0114	$0.05	$728.27 million	$743.17 million
8/3/2026	Q2 2026	WGS GeneDx	-$0.1879	$0.01	+$0.1979	-$0.60	$111.01 million	$114.44 million
7/28/2026	Q2 2026	NEO NeoGenomics	$0.0336	$0.05	+$0.0165	$0.02	$196.93 million	$201.66 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLOV Clover Health Investments	N/A	N/A	N/A	N/A	N/A
NEO NeoGenomics	N/A	N/A	N/A	N/A	N/A
PHLT Performant Healthcare	N/A	N/A	N/A	N/A	N/A
WGS GeneDx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLOV Clover Health Investments	N/A	1.50	1.50
NEO NeoGenomics	0.48	3.60	3.35
PHLT Performant Healthcare	0.10	2.64	2.64
WGS GeneDx	0.40	3.30	3.06

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLOV Clover Health Investments	19.77%
NEO NeoGenomics	98.50%
PHLT Performant Healthcare	77.15%
WGS GeneDx	61.72%

Insider Ownership

Company	Insider Ownership
CLOV Clover Health Investments	23.51%
NEO NeoGenomics	1.10%
PHLT Performant Healthcare	9.10%
WGS GeneDx	25.17%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLOV Clover Health Investments	724	531.16 million	406.28 million	Optionable
NEO NeoGenomics	2,500	128.48 million	127.06 million	Optionable
PHLT Performant Healthcare	930	80.44 million	73.12 million	N/A
WGS GeneDx	1,300	29.82 million	22.32 million	Optionable

PHLT, CLOV, NEO, and WGS Headlines

Recent News About These Companies

Analyzing Brookdale Senior Living (NYSE:BKD) and GeneDx (NASDAQ:WGS)

October 12 at 5:29 AM | americanbankingnews.com

GeneDx Holdings Corp. (NASDAQ:WGS) Stock Rated "Moderate Buy" by Sell-Side Brokerages

October 11 at 2:29 AM | americanbankingnews.com

GeneDx Holdings Corp. (NASDAQ:WGS) Stock Has Average Target Price of $90.86

October 11 at 2:28 AM | marketbeat.com

Top 3 Healthcare Stocks To Watch In October 2026

October 10 at 12:02 AM | finance.yahoo.com

GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026

October 7, 2026 | marketscreener.comM

GeneDx (NASDAQ:WGS) Stock Price Down 6.1% - What's Next?

October 6, 2026 | marketbeat.com

GeneDx Holdings Corp (WGS) Shares Surge 4.3% -- What GF Score of 67 Tells Investors

October 5, 2026 | gurufocus.com

Guggenheim Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock

October 3, 2026 | americanbankingnews.com

GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care

October 2, 2026 | businesswire.com

GeneDx (NASDAQ:WGS) Stock Price Expected to Rise, Guggenheim Analyst Says

October 1, 2026 | marketbeat.com

GeneDx (NASDAQ:WGS) Shares Down 5.9% - Should You Sell?

September 29, 2026 | marketbeat.com

GeneDx Stock Is Down 30% In Last 1 Year, Can It Climb Again in 2027?

September 24, 2026 | finance.yahoo.com

GeneDx (NASDAQ:WGS) Stock Price Up 7.9% - Here's Why

September 24, 2026 | marketbeat.com

GeneDx (NASDAQ:WGS) Stock Price Down 6.5% - Here's Why

September 22, 2026 | marketbeat.com

Corient Private Wealth LP Makes New $3.07 Million Investment in GeneDx Holdings Corp. $WGS

September 21, 2026 | marketbeat.com

GeneDx (NASDAQ:WGS) CFO Sells $363,890.08 in Stock

September 19, 2026 | insidertrades.com

Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells $363,890.08 in Stock

September 18, 2026 | marketbeat.com

GeneDx (NASDAQ:WGS) CEO Sells $1,025,002.61 in Stock

September 18, 2026 | marketbeat.com

GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Rating of "Moderate Buy" from Analysts

September 16, 2026 | marketbeat.com

GeneDx (NASDAQ:WGS) Trading Up 4.2% - What's Next?

September 15, 2026 | marketbeat.com

How Genedx Holdings Corp. (WGS) Affects Rotational Strategy Timing

September 14, 2026 | news.stocktradersdaily.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

PHLT, CLOV, NEO, and WGS Company Descriptions

Clover Health Investments NASDAQ:CLOV

$4.81 +0.03 (+0.63%)

Closing price 04:00 PM Eastern

Extended Trading

$4.85 +0.04 (+0.79%)

As of 07:56 PM Eastern

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

NeoGenomics NASDAQ:NEO

$16.66 +0.46 (+2.84%)

Closing price 04:00 PM Eastern

Extended Trading

$16.61 -0.05 (-0.28%)

As of 07:41 PM Eastern

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

Performant Healthcare NASDAQ:PHLT

Performant Healthcare, Inc. engages in the provision of technology-enabled audit, recovery, customer care, and related analytics services. Its services help identify improper payments, and in some markets, restructure and recover delinquent or defaulted assets and improper payments for both government and private clients. The company was founded in 1976 and is headquartered in Plantation, FL.

GeneDx NASDAQ:WGS

$64.96 +1.14 (+1.79%)

Closing price 04:00 PM Eastern

Extended Trading

$65.69 +0.73 (+1.13%)

As of 07:30 PM Eastern

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PHLT, CLOV, NEO, and WGS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PHLT, CLOV, NEO, and WGS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PHLT, CLOV, NEO, and WGS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PHLT, CLOV, NEO, and WGS Company Descriptions

Clover Health Investments NASDAQ:CLOV

NeoGenomics NASDAQ:NEO

Performant Healthcare NASDAQ:PHLT

GeneDx NASDAQ:WGS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PHLT, CLOV, NEO, and WGS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PHLT, CLOV, NEO, and WGS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PHLT, CLOV, NEO, and WGS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PHLT, CLOV, NEO, and WGS Company Descriptions

Clover Health Investments NASDAQ:CLOV

NeoGenomics NASDAQ:NEO

Performant Healthcare NASDAQ:PHLT

GeneDx NASDAQ:WGS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools